Sort
21,453 grants matching “tuberculosis”
Innovative contact tracing strategies for detecting TB in mobile rural and urban South African populations
$653,812David Wesley Dowdy · Johns Hopkins University · R01 · FY2019 · AI
Animal Model Core
$653,683David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2016 · AI
A TB Vaccine for AIDS Patients
$653,571Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2006 · AI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$653,552Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$653,408Mark Hatherill · University Of Cape Town · R01 · FY2019 · AI
The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
$653,365Timothy W Schacker · University Of Minnesota · U01 · FY2022 · AI
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$653,337Christopher D Heaney · Johns Hopkins University · R01 · FY2017 · ES
REGULATION OF LIPID METABOLISM IN BACTERIA
$653,244Charles O Rock · St. Jude Children'S Research Hospital · R37 · FY2009 · GM
Strategies for tuberculosis control in prisons
$653,230Jason Randolph Andrews · Stanford University · R01 · FY2024 · AI
CREATING ANTIBODIES TO ENABLE THE STUDY OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS IN GUINEA PIGS
$653,191Ron Orlando · Glycoscientific, Llc · N43 · FY2019 · AI
Trial of Vitamin D Supplementation to Prevent TB Infection in Schoolchildren
$653,121Ganmaa Davaasambuu · Harvard School Of Public Health · R01 · FY2015 · HL
Targeting Hsp90 in cryptococcal fungal pathogenesis
$653,100Leah Elizabeth Cowen · University Of Toronto · R01 · FY2024 · AI
Lung immune function in human TB infection and its perturbation by HIV-1.
$653,018David G Russell · Cornell University · R01 · FY2024 · AI
PK-PD of combination antituberculosis therapy for suppression of drug-resistance
$652,875Tawanda Gumbo · Ut Southwestern Medical Center · R01 · FY2008 · AI
J. NRSA Training Core
$652,865Olaf S Andersen · Weill Medical Coll Of Cornell Univ · TL1 · FY2022 · TR
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
$652,766Robert H Gilman · Johns Hopkins University · R01 · FY2020 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$652,709Sarah Burkholder · Indiana State Department Of Health · U52 · FY2008 · PS
Latent and Reactivation Tuberculosis
$652,651Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · HL
Development of novel anti-TB drugs that inhibit cell wall biosynthesis and respiration
$652,628David Alland · Hackensack University Medical Center · U19 · FY2021 · AI
Defining host-pathogen oxysterol co-metabolites and their role in TB pathogenesis
$652,582Jennifer A Philips · Washington University · R01 · FY2024 · AI
M. tuberculosis carbon metabolism during infection
$652,282Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
Tuberculosis Elimination and Laboratory Cooperative Agreements
$652,240Scott Allen Clardy · Missouri State Dept/ Health & Senior Srv · U52 · FY2010 · PS
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens
$652,173Chetan Seshadri · University Of Washington · R01 · FY2020 · AI
Targeting trans-translation to kill M. tuberculosis non-replicating persister cells
$652,094Kenneth C Keiler · Pennsylvania State University, The · R01 · FY2024 · AI
Genetic predisposition to tuberculosis in Morocco
$652,035Jean-Laurent Casanova · Rockefeller University · U01 · FY2011 · AI